pemirolast has been researched along with piperidines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossen, MA; Kamei, C; Minami, K | 1 |
| Fujishima, H; Fukagawa, K; Fukushima, A; Miyazaki, D; Nakagawa, Y; Okamoto, S; Takamura, E; Tanaka, M; Uchio, E; Yokoi, N | 1 |
| Ben-Eli, H; Solomon, A | 1 |
1 review(s) available for pemirolast and piperidines
| Article | Year |
|---|---|
Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Cromolyn Sodium; Dibenzazepines; Histamine Antagonists; Humans; Hyperemia; Imidazoles; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Phthalazines; Piperidines; Pruritus; Pyridines; Pyrimidinones | 2018 |
1 trial(s) available for pemirolast and piperidines
| Article | Year |
|---|---|
The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctivitis, Allergic; Drug Therapy, Combination; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukocyte Count; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Pyridines; Pyrimidinones; Treatment Outcome | 2008 |
1 other study(ies) available for pemirolast and piperidines
| Article | Year |
|---|---|
Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
Topics: Animals; Conjunctivitis, Allergic; Drug Synergism; Drug Therapy, Combination; Histamine Release; Male; Piperidines; Pyridines; Pyrimidinones; Rats; Rats, Wistar | 2005 |